NCT07759245
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT07759245
- Registry
- ClinicalTrials.gov
- NCT number
- NCT07759245
- CTIS number
- 2026-525480-41-00
- Sponsor, as registered
- Eli Lilly and Company
- Phase
- PHASE2
- Indication
- Pulmonary Disease, Chronic Obstructive
- Status
- RECRUITING
- Start date
- 2026-08-07
- Primary completion
- 2028-05
- Registered countries
- Argentina, Austria, Canada, China, Czechia, Denmark, France, Germany, Hungary, India, Japan, Mexico, Poland, Puerto Rico, Romania, South Korea, United Kingdom, United States
- Sites
- 127
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-09-28
Notes on the record
Fields read from the ClinicalTrials.gov v2 API record. countries is the distinct country list across all registered locations; site_count is the number of location entries, which counts a country once per site, not once per country. Added 2026-09-28 from the Issue 16 collection: the record was updated in the 21 to 28 September window (LastUpdatePostDate 2026-09-25). Companion CTIS record T-ctis-2026-525480-41-00 added the same session.
Company
Through brenipatide (LY3537031): Lilly
Cited in
No published issue cites this registry number.